Foreign capital explodes to buy film and television lithium battery! 25X big bull stocks fell by the limit of 1.8 million and closed with their hands!

After two consecutive days of prosperity, A-Shares have made a correction this morning, and many heavy stocks have suddenly fallen by the limit or plummeted. There is the depression of Chinese new shares, the breaking of A-Shares in Hong Kong and the breaking of the limit of lithium leading. Individual stocks are wonderful. Lenovo suddenly issued a heavy statement.

The 25 times Bull Stock Jiangxi Special Electric Motor Co.Ltd(002176) was suddenly put on file. As expected, it fell by the limit at the opening. After the 36 billion brokerage Soochow Securities Co.Ltd(601555) threw out the 8.5 billion share allotment plan, the share price plummeted. Investors who won the new shares of n Dizhe on the science and Innovation Board lost 5000 yuan in the morning, and the new shares of Hong Kong stocks fell 29% in the session. The price limit of Qinghai Salt Lake Industry Co.Ltd(000792) lithium extraction leader in Salt Lake with a market value of 180 billion broke out.

In the morning, the main indexes of A-Shares opened low and then rebounded. At the end of the morning, the Shanghai index fell 0.32%, the Shenzhen Component Index fell 0.24%, and the gem index rose 0.28%. The turnover between the two cities was 730.2 billion yuan, 2310 stocks rose and 2087 stocks fell.

Northbound capital continued to sweep a shares, with a net purchase of 5.8 billion yuan in the morning.

concepts such as lithium extraction from Salt Lake, meta universe and polycrystalline silicon ranked first

In the morning, salt lake lithium, film and television stocks, yuanuniverse, polysilicon and other concept stocks led the gains.

Brokerage stocks led the decline.

media, film and television stocks were active, Zhejiang Talent Television & Film Co.Ltd(300426) rose by more than 15%

In terms of the industry, the media, film and television sector with “ten thousand years of no rise” was active, with the increase being ahead, Zhejiang Talent Television & Film Co.Ltd(300426) and Beijing Hualubaina Film&Tv Co.Ltd(300291) both rose by more than 15%.

Mineral products, chemical industry and the Internet also rose well, while petroleum, engineering machinery and building materials fell ahead.

25 times super bull stocks suddenly fell by the limit

On December 9, Jiangxi Special Electric Motor Co.Ltd(002176) announced that the CSRC decided to file a case against the company for suspected illegal information disclosure. According to the announcement, on December 9, 2021, the company received the notice on filing (Zheng Jian Li Jian Li Jian Zi No. 025201009) from China Securities Regulatory Commission (hereinafter referred to as “CSRC”). Due to suspected illegal information disclosure, according to the securities law of the people’s Republic of China, the administrative punishment law of the people’s Republic of China and other laws and regulations, The CSRC decided to file a case against the company.

Jiangxi Special Electric Motor Co.Ltd(002176) is one of the leading stocks in this round of new energy bull market. In May 2020, the stock price was once as low as 1.25 yuan. In other words, in a short period of more than one year, the stock increased by more than 25 times. As of the third quarterly report of this year, Jiangxi Special Electric Motor Co.Ltd(002176) shareholders had reached 209600.

Suddenly encountered major bad news, this morning Jiangxi Special Electric Motor Co.Ltd(002176) fell to the limit, and 1.83 million orders were sold on the limit board. In the morning Jiangxi Special Electric Motor Co.Ltd(002176) closed down 9.98% to 21.55 yuan, with a market value of 36.7 billion yuan.

According to public information, Jiangxi Special Electric Motor Co.Ltd(002176) is a national high-tech enterprise integrating R & D, production and sales of intelligent electromechanical products, lithium products and electric vehicles.

According to public data, in the first half of 2021, Jiangxi Special Electric Motor Co.Ltd(002176) achieved an operating revenue of 1.365 billion yuan, a year-on-year increase of 50.02%; The net profit was 181 million yuan, a year-on-year increase of 6442.29%; Earnings per share is 0.11 yuan.

In 2021, the company’s motor business grew steadily, and the increase of lithium business volume and price boosted the performance reversal.

share allotment financing of RMB 8.5 billion and RMB 36 billion Soochow Securities Co.Ltd(601555) plummeted

After the hot brokerage stocks in the previous two days, yesterday’s Soochow Securities Co.Ltd(601555) with a market value of 36.5 billion suddenly threw out a stock allotment plan with a market value of 8.5 billion, which has always been the “money” plan of all investors, which triggered an investment sell-off. This morning Soochow Securities Co.Ltd(601555) shares plunged 6.59%, leading the decline among brokerage stocks, much higher than the 1.49% decline of the plate.

At the end of the third quarter, Soochow Securities Co.Ltd(601555) shareholders numbered 120400.

On December 9, Soochow Securities Co.Ltd(601555) announced that it planned to allot 10 shares with 3 shares to all shareholders, and the financing for the allotment would not exceed 8.5 billion yuan. The allotment price is 7.19 yuan / share, Soochow Securities Co.Ltd(601555) the latest closing price on December 9 is 9.41 yuan, and the allotment price is about 24% lower than the latest share price.

According to the announcement, the allotment is based on 3838817394 shares of the company’s total share capital after the closing of the market on December 14, 2021 (t day) after the equity registration date, deducting 41701514 shares held in the company’s special repurchase account, and shares are allotted to all shareholders (excluding the company’s special repurchase account) in the proportion of 3 shares per 10 shares.

The total number of shares that can be allotted this time is 1151645218 shares, all of which are tradable shares with unlimited sales conditions. They are issued by online pricing. The allotment code is “760555”, and the allotment is referred to as “Soochow allotment”, which is carried out through the Shanghai stock exchange system. The total amount of funds raised in this allotment is expected to not exceed 8.5 billion yuan.

The allotment price is 7.19 yuan / share.

Intraday limit of 180 billion salt lake lithium extraction leader

Although the market was generally flat in the morning, the 175 billion market value Salt Lake Lithium leader Qinghai Salt Lake Industry Co.Ltd(000792) still closed the daily limit and opened the daily limit in the morning.

More than 50 billion Chengxin Lithium Group Co.Ltd(002240) also rose by the limit.

continuous trading of multiple stocks: Yunnan Xiyi Industrial Co.Ltd(002265) 5 one word trading

Acquisition of military assets, Yunnan Xiyi Industrial Co.Ltd(002265) five consecutive one word limit.

On December 3 Yunnan Xiyi Industrial Co.Ltd(002265) the reorganization plan was disclosed. The company plans to purchase 100% equity of Chongqing construction industry (Group) Co., Ltd. (hereinafter referred to as “construction industry”) from ordnance equipment group and raise supporting funds.

Auto parts concept stock Zhejiang Yueling Co.Ltd(002725) also rose for five consecutive days.

Hydrogen energy concept stocks, after clarification, surged by more than 6% this morning for seven consecutive trading limits of Beijing Jingcheng Machinery Electric Company Limited(600860) .

Beijing Jingcheng Machinery Electric Company Limited(600860) said that the company’s main business is the manufacturing of gas storage and transportation equipment, which does not involve the hydrogen energy battery industry, and the sales revenue of the company’s hydrogen storage bottles and other related products accounts for a relatively small proportion compared with other main products of the company, which has a limited contribution to the company’s performance. The company has not found any media reports or market rumors that may have a significant impact on the company’s stock trading price, and the company has not found any other major events that may have a significant impact on the company’s stock price.

new shares are too difficult. A-Shares and Hong Kong shares all broke, falling 27% on the first day

Not only Hong Kong stocks, but also A-share new shares break on the first day. Among the three new shares listed on the A-share market today, n Dizhe, a new share on the science and innovation board, broke. The issue price of the stock was 52.58 yuan, which once fell to 41.5 yuan in the intraday, and the share price fell by about 20%. The first signing will lose more than 5000 yuan. CXO leading stock Asymchem Laboratories (Tianjin) Co.Ltd(002821) also broke its listing in Hong Kong stocks today.

The issuing price of Dizhe pharmaceutical was 52.58 yuan / share, and the net fund-raising was 1.783 billion yuan. The raised funds were used for new drug R & D projects (1.483 billion yuan) and supplementary working capital (300 million yuan). It is proposed to raise 1.783 billion yuan for new drug R & D projects (1.483 billion yuan) and supplementary working capital (300 million yuan).

Dizhe pharmaceutical is jointly funded by SDIC innovation and AstraZeneca. Most of the core teams come from AstraZeneca China Innovation Center. It takes only four years from its establishment in November 2017 to its application for listing on the science and innovation board in 2021.

At present, Dizhe pharmaceutical has no controlling shareholder and actual controller. As of the signing date of the prospectus, both advanced manufacturing under SDIC innovation and azab under AstraZeneca held 30.2564% of the voting rights of the company, with the same proportion of voting rights, and there was no subordinate relationship or concerted action relationship between the two parties.

The products under research of Dizhe medicine are small molecule drugs, which are mainly focused on malignant tumors and autoimmune diseases at this stage, and four products have entered the clinical stage. Among them, one product is in phase III or phase II critical clinical stage, one product is in phase II non critical clinical stage, and two products are in phase I clinical stage.

The new share of Hong Kong stocks, Hokkaido Kangcheng, fell 28.82% during the session.

The rare disease treatment “unicorn” Beihai kangcheng-b (01228) was officially listed on the Hong Kong Stock Exchange today (December 10). The listing plans to issue 56.251 million shares, with another 15% over allotment of equity. Morgan Stanley and Jefferies are co sponsors.

In this IPO, Hokkaido Kangcheng and six cornerstone investors (including RA capital, Hudson Bay, Janus capital, Yaoming biology, etc.) have entered into a cornerstone investment agreement and agreed to subscribe for shares with a total amount of about US $60 million at the offering price.

It is reported that Hokkaido Kangcheng, founded in 2012, is a biomedical company based in China and focusing on rare diseases. It is committed to research, development and commercialization of biotechnology therapy. At present, the company has built a comprehensive pipeline composed of 13 drug assets with great market potential, including three listed products, four candidate drugs in the clinical stage, one in the ind preparation stage, two in the preclinical stage, and the other three gene therapy projects are in the pilot identification stage.

One of the company’s main products, hunterase, a biotherapy for the rare disease hunter’s syndrome or MPS II, was approved for listing in China last September and is expected to be included in China’s national and upgraded medical insurance catalogue in the next few years. Hunterase has submitted an application to the national medical insurance catalogue and the provincial medical insurance catalogue of 13 provinces. It is the first rare disease drug successfully commercialized by Hokkaido Kangcheng in China. It is also China’s first and only global new generation enzyme replacement therapy (ERT) for MPS II. It has FDA orphan drug qualification certification, And previously obtained the priority review qualification of the food and drug administration, filling the gap in the field of clinical treatment of MPS Ⅱ indications in China. It is estimated that there are more than 8000 patients in China. It is believed that there is a high probability that they can enter the list of different levels of medical insurance in the future. In 2020, the global sales of mpsii drugs reached US $629 million. From the perspective of market competition pattern, hunterase is the only available MPS II targeted therapy in China. Therefore, in the face of the growing treatment market gap, hunterase has unique advantages in commercialization and great market development potential.

In addition, the company has established major operation centers in Beijing and Shanghai and offices in other regions of Greater China. It plans to expand to major target provinces in China and set up local offices. At present, the company is expanding its targeted internal commercialization team, which is expected to expand to more than 300 people in the next five years.

Lenovo Holdings: 29% equity transfer in 2009 was legal and in accordance with regulations

On December 10, Lenovo holdings issued a statement on the intranet today in response to matters related to equity transfer. Lenovo Holdings said in a statement that in 2009, in accordance with the relevant provisions on the transaction of state-owned assets of enterprises, Chinese Academy of Sciences Holdings Co., Ltd. transferred 29% of the equity of Lenovo holdings through public listing and trading in Beijing property exchange. This transfer has been audited, evaluated and filed in strict accordance with the relevant requirements of state-owned asset property right transaction.

Lenovo Holdings said that the book value of the owner’s equity attributable to the parent company of Lenovo holdings was 7.72 billion yuan and the assessed value was 9.26 billion yuan. In this transaction, Lenovo Holdings’ owner’s equity premium attributable to the parent company reached 9.5 billion yuan, and the corresponding 29% equity transaction price was 2.755 billion yuan.

Lenovo stressed that this equity transfer has maintained and increased the value of state-owned assets, and no objection has been raised in previous central inspections and audits by the National Audit Office.

The following is the full text of the statement:

The following facts have been confirmed with the Chinese Academy of Sciences Holding Co., Ltd.

In August 2004, in accordance with the requirements of the CPC Central Committee on “vigorously developing the mixed ownership economy with the participation of state-owned capital, collective capital and non-public capital and realizing the diversification of investors”, in order to accelerate the large-scale development of high-tech industry, CAS made the decision to accelerate the equity socialization reform of enterprises invested by CAS.

In 2009, in accordance with the relevant provisions on the transaction of state-owned assets of enterprises, Chinese Academy of Sciences Holdings Co., Ltd. transferred 29% of the equity of Lenovo holdings through public listing and trading in Beijing property exchange. This transfer has been audited, evaluated and filed in strict accordance with the relevant requirements of state-owned asset property right transaction.

The book value of the owner’s equity of Lenovo holdings attributable to the parent company is 7.72 billion yuan and the assessed value is 9.26 billion yuan. In this transaction, Lenovo Holdings’ owner’s equity premium attributable to the parent company reached 9.5 billion yuan, and the corresponding 29% equity transaction price was 2.755 billion yuan.

This equity transfer has realized the preservation and appreciation of state-owned assets, and no objection has been raised in previous central inspections and audits by the National Audit Office.

On the morning of December 10, Lenovo holdings fell 1.76%, with the latest market value of HK $29 billion.

future strategy

Theme strategy of eight securities companies: resource shortage + year-end stock tide! “Lithium uncle” welcomes the highlights and combs the beneficiary stocks at the moment

Free research report selection: the investment window of domestic parts is exposed, and the seed industry ushers in a historic configuration opportunity! What are the potential targets?

Meisheng Cultural & Creative Corp.Ltd(002699) 3 connecting plate! More leading staged 20cm limit, the concept of Yuan universe is hot! The textile and garment sector also took off

(China Fund News)



- Advertisment -